drugset / Trial / NCT00352495
Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy, such as vinblastine and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of vinblastine when given together with carboplatin in treating young patients with newly diagnosed or recurrent low-grade glioma.
Timeline
- Start
- 2006-06
- Primary completion
- 2011-09
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 140 mg/m2 | Intravenous |
| Subject | Carboplatin | Small molecule | 300 mg/m2 | Intravenous |
| Subject | Carboplatin | Small molecule | 400 mg/m2 | Intravenous |
| Subject | Carboplatin | Small molecule | 500 mg/m2 | Intravenous |
| Subject | Vinblastine | Small molecule | 3.5 mg/m2 | Intravenous |
| Subject | Vinblastine | Small molecule | 4 mg/m2 | Intravenous |
| Subject | Vinblastine | Small molecule | 4.5 mg/m2 | Intravenous |